{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:53:44Z","timestamp":1783716824763,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.contraception.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T23:20:09Z","timestamp":1345072809000},"page":"352-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women"],"prefix":"10.1016","volume":"87","author":[{"given":"Alison B.","family":"Edelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Doom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Hennebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.07.004_bb0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.contraception.2004.05.007","article-title":"Pituitary\u2013ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation","volume":"70","author":"Croxatto","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.004_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.07.004_bb0015","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/humrep\/deq157","article-title":"Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture","volume":"25","author":"Brache","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1095\/biolreprod.102.008425","article-title":"Rescue of the corpus luteum in human pregnancy","volume":"68","author":"Baird","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/me.2007-0484","article-title":"Systematic determination of differential gene expression in the primate corpus luteum during the luteal phase of the menstrual cycle","volume":"22","author":"Bogan","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.contraception.2012.07.004_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/jcem-55-1-102","article-title":"Progesterone and adenosine 3',5'-monophosphate formation by isolated human corpora lutea of different ages: influences of human chorionic gonadotropin and prostaglandins","volume":"55","author":"Dennefors","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.004_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1210\/jcem-66-5-909","article-title":"Luteotropic effects of prostaglandin E2 on the human corpus luteum of the menstrual cycle and early pregnancy","volume":"66","author":"Hahlin","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.004_bb0040","series-title":"The physiology of reproduction","first-page":"1995","article-title":"Recognition and maintenance of pregnancy","author":"Hodgen","year":"1988"},{"key":"10.1016\/j.contraception.2012.07.004_bb0045","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1210\/endo-123-5-2261","article-title":"Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys","volume":"123","author":"Sargent","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.07.004_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1095\/biolreprod43.3.507","article-title":"Intraluteal infusions of prostaglandins of the E, D, I, and A series prevent PGF2 alpha-induced, but not spontaneous, luteal regression in rhesus monkeys","volume":"43","author":"Zelinski-Wooten","year":"1990","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0055","series-title":"The physiology of reproduction","first-page":"475","article-title":"Structure, function, and regulation of the corpus luteum","author":"Stouffer","year":"2006"},{"key":"10.1016\/j.contraception.2012.07.004_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1095\/biolreprod20.4.897","article-title":"Disparate effects of prostaglandins on basal and gonadotropin-stimulated progesterone production by luteal cells isolated from rhesus monkeys during the menstrual cycle and pregnancy","volume":"20","author":"Stouffer","year":"1979","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0065","doi-asserted-by":"crossref","first-page":"37117","DOI":"10.1074\/jbc.M608202200","article-title":"Cyclooxygenase-2-derived prostaglandin E(2) directs oocyte maturation by differentially influencing multiple signaling pathways","volume":"281","author":"Takahashi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.contraception.2012.07.004_bb0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/378406a0","article-title":"Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II","volume":"378","author":"Dinchuk","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.contraception.2012.07.004_bb0075","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1210\/en.2008-0500","article-title":"Prostaglandin synthesis, metabolism, and signaling potential in the rhesus macaque corpus luteum throughout the luteal phase of the menstrual cycle","volume":"149","author":"Bogan","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.07.004_bb0080","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1210\/en.2003-1607","article-title":"Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function","volume":"145","author":"Arosh","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.07.004_bb0085","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0091270006289483","article-title":"Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study","volume":"46","author":"Bata","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2012.07.004_bb0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/humrep\/dep392","article-title":"Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception","volume":"25","author":"Jesam","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/humrep\/del369","article-title":"Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study","volume":"22","author":"Massai","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/humrep\/dep424","article-title":"Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception","volume":"25","author":"Hester","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0105","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/16.7.1323","article-title":"Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study","volume":"16","author":"Pall","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.004_bb0110","series-title":"Table\u00a036.5. Foyle's principles of medicinal chemistry","author":"Lemke","year":"2008"},{"key":"10.1016\/j.contraception.2012.07.004_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.contraception.2010.01.004","article-title":"A nonhormonal model for emergency contraception: prostaglandin synthesis inhibitor effects on luteal function and lifespan, a pilot study","volume":"81","author":"Edelman","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1124\/dmd.105.006452","article-title":"Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?","volume":"33","author":"Rodrigues","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.contraception.2012.07.004_bb0125","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/humrep\/17.11.2825","article-title":"Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys","volume":"17","author":"Duffy","year":"2002","journal-title":"Hum Reprod"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:45:02Z","timestamp":1761432302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412006701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0010782412006701"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954852.793462016","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}